Psychedelics Archives - Page 60 of 68

2 minute read

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson’s Disease

September 17, 6:09 PM

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced Friday that the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at the MDS

CSE:PHRM

1 minute read

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details

By Lara Goldstein

September 17, 6:05 PM

Canadian-based psychedelics company Nova Mentis Life Science Corp.

NMLSF

2 minute read

Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year

By Lara Goldstein

September 17, 6:01 PM

Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and business highlights for the three months ended July 31, 2022. During the period, numbers reflected:

AWKNF

2 minute read

Wellbeing Digital Reports 4Q Finances, ‘Three Key Pillars’ Stay Strong

By Lara Goldstein

September 16, 4:05 PM

Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed:

KONEF

1 minute read

Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction

By Lara Goldstein

September 16, 3:10 PM

Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.

RVVTF

2 minute read

This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ

By Lara Goldstein

September 15, 2:36 PM

The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.

MNMD

3 minute read

Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma

By Lara Goldstein

September 14, 7:02 PM

Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options

DMTTF

2 minute read

Psychedelics Companies Are Teaming Up To Offer Access Veterans

By Lara Goldstein

September 13, 8:16 PM

Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans.

AWKNF

4 minute read

Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here

By Lara Goldstein

September 13, 2:12 PM

The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions around the natural plant and synthetic medicines revolutionizing mental health.

ATAI

2 minute read

Psychedelics Companies Seek Innovative Methods To Deliver Assisted Therapies, This One Stands Out

By Lara Goldstein

September 12, 2:32 PM

As competence grows, biopharmaceuticals are searching for ways to present their specific psychedelic substance-assisted therapies in a way that might differentiate them from their competitors while maintaining safety and efficiency standards.

AWKNF